Article Versions Notes

Vobugari N, Makovec A, Kellen S, Nazari SS, Elliott A, Schmeck D, Deacon A, von Dohlen G, John E, Barata PC, et al. HSD3B1 (c.1100C) Genotype Is Associated with Distinct Tumoral and Clinical Outcomes in Breast and Endometrial Cancers. International Journal of Molecular Sciences. 2025; 26(12):5720. https://doi.org/10.3390/ijms26125720

Vobugari, Nikitha, Allison Makovec, Samuel Kellen, Shayan S. Nazari, Andrew Elliott, Devin Schmeck, Aiden Deacon, Gabriella von Dohlen, Emily John, Pedro C. Barata, and et al. 2025. "HSD3B1 (c.1100C) Genotype Is Associated with Distinct Tumoral and Clinical Outcomes in Breast and Endometrial Cancers" International Journal of Molecular Sciences 26, no. 12: 5720. https://doi.org/10.3390/ijms26125720

Vobugari, N., Makovec, A., Kellen, S., Nazari, S. S., Elliott, A., Schmeck, D., Deacon, A., von Dohlen, G., John, E., Barata, P. C., Agarwal, N., Geller, M. A., Erickson, B. K., Sledge, G., Ostrander, J. H., McKay, R. R., Ryan, C. J., Sharifi, N., Antonarakis, E. S., & Hwang, J. (2025). HSD3B1 (c.1100C) Genotype Is Associated with Distinct Tumoral and Clinical Outcomes in Breast and Endometrial Cancers. International Journal of Molecular Sciences, 26(12), 5720. https://doi.org/10.3390/ijms26125720